Headache: challenging conventional wisdom

David W. Dodick; Todd Schwedt

doi:10.1016/S1474-4422(08)70275-8

Headache: challenging conventional wisdom

David W. Dodick, Todd Schwedt

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	12-14
Number of pages	3
Journal	The Lancet Neurology
Volume	8
Issue number	1
DOIs	https://doi.org/10.1016/S1474-4422(08)70275-8
State	Published - Jan 2009

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1016/S1474-4422(08)70275-8

Cite this

@article{d1a4284800c44da1a4d2baf7314e8169,

title = "Headache: challenging conventional wisdom",

author = "Dodick, {David W.} and Todd Schwedt",

note = "Funding Information: DWD has been an advisory board consultant for Merck, Allergan, Endo, Pfizer, Coherex, Neuralieve, MAP Pharmaceuticals, and Minster Pharmaceuticals. He has received research support from ANS, Medtronic, and St Jude, and was the principal investigator for the ESCAPE study (Effect of Septal Closure of Atrial PFO on Events of Migraine With Premere). TS has received research support from the National Institutes of Health and National Headache Foundation and has consulted for VerusMed. He has particpated in industry-sponsored research from Allergan, GlaxoSmithKline, and AGA Medical.",

year = "2009",

month = jan,

doi = "10.1016/S1474-4422(08)70275-8",

language = "English (US)",

volume = "8",

pages = "12--14",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Lancet Publishing Group",

number = "1",

}

TY - JOUR

T1 - Headache

T2 - challenging conventional wisdom

AU - Dodick, David W.

AU - Schwedt, Todd

N1 - Funding Information: DWD has been an advisory board consultant for Merck, Allergan, Endo, Pfizer, Coherex, Neuralieve, MAP Pharmaceuticals, and Minster Pharmaceuticals. He has received research support from ANS, Medtronic, and St Jude, and was the principal investigator for the ESCAPE study (Effect of Septal Closure of Atrial PFO on Events of Migraine With Premere). TS has received research support from the National Institutes of Health and National Headache Foundation and has consulted for VerusMed. He has particpated in industry-sponsored research from Allergan, GlaxoSmithKline, and AGA Medical.

PY - 2009/1

Y1 - 2009/1

UR - http://www.scopus.com/inward/record.url?scp=57149098581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149098581&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(08)70275-8

DO - 10.1016/S1474-4422(08)70275-8

M3 - Comment/debate

C2 - 19081504

AN - SCOPUS:57149098581

SN - 1474-4422

VL - 8

SP - 12

EP - 14

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 1

ER -

Headache: challenging conventional wisdom

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this